Alexa Fluor® 488 anti-mouse CD3 Antibody
- 产品名称：
- Alexa Fluor® 488 anti-mouse CD3 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 100212
- 产品应用：
- 100212
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- γδTCR-positive T-T hybridoma D1
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 488 under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
IHC-F, 3D IHC - Verified
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?L?volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 ?g per mL. For 3D immunohistochemistry on formalin-fixed tissues, a concentration of 5.0 ?g/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
* Alexa Fluor? 488 has a maximum emission of 519 nm when it is excited at 488 nm.
Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser
- Blue Laser (488 nm)
- Application Notes
Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.
- Application References
(PubMed link indicates BioLegend citation) -
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Schneider C, et al. 2018. Cell. 174:271. PubMed
- Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
- Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
- Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
- Bieber M, et al. 2021. Int J Mol Sci. 22:. PubMed
- Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
- Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
- Dauer Née Joppe K, et al. 2021. J Neurochem. 159:554. PubMed
- Upadhyaya P, et al. 2021. J Immunother Cancer. 9:00. PubMed
- Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
- Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
- Logan C, Bowen C, and Menko A 2017. Sci Rep. . 10.1038/s41598-017-16456-5. PubMed
- Brandt S, et al. 2020. J Am Soc Nephrol. 31:2589. PubMed
- Park JJ, et al. 2021. Nat Commun. 12:1222. PubMed
- Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
- Wang C, et al. 2021. Cell Stem Cell. . PubMed
- Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
- Lau CH, et al. 2022. Antioxidants (Basel). 11:. PubMed
- Wan W, et al. 2013. Cardiovasc Res. 97:580. PubMed
- Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
- Amor C, et al. 2020. Nature. 583:127. PubMed
- Wei SC, et al. 2020. Cancer Discov. . PubMed
- Mills C, et al. 2022. Cells. 11:. PubMed
- Wong HS, et al. 2021. Cell. . PubMed
- Xiao S, et al. 2007. J Exp Med. 204:1691. PubMed
- Mooney C, et al. 2017. International Journal of Molecular Sciences. 10.3390/ijms18051037. PubMed
- Hsieh C, et al. 2014. J Immunol. 193:3693. PubMed
- Counoupas C, et al. 2020. NPJ Vaccines. 0.28125. PubMed
- Wang B, et al. 2021. J Immunother Cancer. 9:. PubMed
- Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
- Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
- Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
- Broderick L, et al. 2019. Nat Commun. 10:3644. PubMed
- Karandikar SH, et al. 2019. Anal Chem. 91:3405. PubMed
- Riding AM, et al. 2022. iScience. 25:104660. PubMed
- Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
- Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
- Wang S, et al. 2022. J Inflamm Res. 14:7107. PubMed
- Li MY, et al. 2021. Developmental Cell. :. PubMed
- MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
- Cheng Q, et al. 2018. PLoS Pathog. 14:e1007440. PubMed
- Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
- Zhao L,et al. 2017. Nat Commun. . 10.1038/s41467-017-01181-4. PubMed
- Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
- Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
- Thurlow LR, et al. 2018. Cell Host Microbe. 24:261. PubMed
- Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
- Lee-Sayer SSM, et al. 2018. Eur J Immunol. 48:803. PubMed
- Zhou P, et al. 2022. Mol Ther Oncolytics. 25:236. PubMed
- Kuhn NF et al. 2019. Cancer cell. 35(3):473-488 . PubMed
- Hsing CH, et al. 2021. Biomedicines. 9:. PubMed
- RRID
- AB_493530 (BioLegend Cat. No. 100212) AB_389301 (BioLegend Cat. No. 100210)
- Structure
- Ig superfamily, CD3/TCR, 20 kD
- Distribution
-
Thymocytes (differentiation dependent), mature T cells, NK-T cells
- Function
- Antigen recognition, TCR signal transduction, T cell activation
- Ligand/Receptor
- Peptide antigen/MHC-complex
- Antigen References
-
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.
- Gene ID
- 12502 View all products for this Gene ID
- UniProt
- View information about CD3 on UniProt.org
